PRECIGEN, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PRECIGEN, INC. stock issued during period, value, issued for services for the quarter ending 2026-06-30 was $0.00.
- PRECIGEN, INC. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $526.00K, a 0.19% decline year-over-year.
- PRECIGEN, INC. stock issued during period, value, issued for services for the quarter ending 2025-12-31 was $0.00.
- PRECIGEN, INC. stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- PRECIGEN, INC. stock issued during period, value, issued for services for fiscal 2025 was $527.00K, a 4.70% decline from fiscal 2024.
- PRECIGEN, INC. stock issued during period, value, issued for services for fiscal 2024 was $553.00K, a 1.47% increase from fiscal 2023.
- PRECIGEN, INC. stock issued during period, value, issued for services for fiscal 2023 was $545.00K, a 5.22% decline from fiscal 2022.
- PRECIGEN, INC. stock issued during period, value, issued for services for fiscal 2022 was $575.00K, a 0.35% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $526.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $526.00K 10-Q · filed 2026-05-13 | $526.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $527.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $527.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $552.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $527.00K 10-Q · filed 2026-05-13 | $552.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $553.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $25.00K 10-Q · filed 2025-11-13 | $553.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $528.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | $528.00K 10-Q · filed 2025-05-14 | $528.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $545.00K 10-K · filed 2026-03-25 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $544.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $544.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-03-31 | $545.00K 10-Q · filed 2024-05-14 | $544.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2022-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $575.00K 10-K · filed 2025-03-19 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $576.00K derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $576.00K derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-03-31 | $576.00K 10-Q · filed 2023-05-10 | $576.00K derived: sum of 4 quarters · filed 2024-03-19 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $577.00K 10-K · filed 2024-03-19 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $577.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $653.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $577.00K 10-Q · filed 2022-05-09 | $653.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $1.01M 10-K · filed 2023-03-06 |
| 2020-09-30 | $76.00K 10-Q · filed 2021-11-08 | $3.46M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $5.69M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $930.00K 10-Q · filed 2021-05-10 | $10.54M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $10.45M 10-K · filed 2022-03-01 |
| 2019-09-30 | $2.30M 10-Q · filed 2019-11-12 | $10.28M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $4.86M 10-Q · filed 2020-08-10 | $10.90M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $831.00K 10-Q · filed 2020-05-11 | $8.59M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $10.70M 10-K · filed 2021-03-01 |
| 2018-09-30 | $2.92M 10-Q · filed 2019-11-12 | $11.08M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $2.55M 10-Q · filed 2019-08-09 | $10.89M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $2.94M 10-Q · filed 2019-05-09 | $11.14M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $11.12M 10-K · filed 2020-03-02 |
| 2017-09-30 | $2.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $10.93M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $10.80M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $2.92M 10-Q · filed 2017-05-10 | $10.61M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $10.78M 10-K · filed 2019-03-01 |
| 2016-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | |
| 2016-06-30 | $2.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | |
| 2016-03-31 | $3.08M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $2.17M 10-K · filed 2018-03-01 | |
| 2014-12-31 | $486.00K 10-K · filed 2017-03-01 | |
| 2013-12-31 | $124.00K 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |